Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia
NCT00804297
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Hypoglycemia
Diabetes Mellitus
Interventions
DRUG:
Octreotide (drug)
Sponsor
Albert Einstein Healthcare Network